Drug trial defies Wall Street’s ‘wisdom’

The news on a trial of an in-development Alzheimer’s drug missed the point — a potential treatment that could help millions. But smart investors read past the headline.

Random Posts:

Leave a Reply

You must be logged in to post a comment.